3D Printing in Healthcare: The Future is Here

IMTS

Share this Article

Additive manufacturing (AM) is revolutionizing a variety of industries, and healthcare is ripe for transformation. According to SME, the 3D printed medical devices market is expected to near $26 billion over the next two years. Moreover, the medical sector already accounts for 17 percent of the total AM market, and the market share is expected to grow as even more manufacturers expand beyond prototyping. 

Simply put: If you’re not yet utilizing 3D printing, you’re behind the competition.

Thanks to the flexible nature of AM, manufacturers are no longer beholden to large-series productions. With 3D printing, you can help medical providers develop equipment and tools with intricate designs and geometries, allow them to better react to condensed delivery times and financial barriers, and provide functional integration — all with a patient care journey that’s more personalized than ever before. 

Personalized healthcare represents one of the most significant areas of growth potential in the medical space. Using 3D printing to personalize products, tools, and devices enables you to cater to the physiological and functional aspects of individual patients and medical staff. 

For example, providing customized surgical tools can enhance procedures and improve a surgeon’s dexterity or ability to serve a specific patient population. A surgeon might naturally hold a tool or device in a way that’s not standard because of their grip preference, hand size, or other physiological differences. They could also have a special surgical technique for a particular patient population which could be better served by a tool designed to meet their technique, instead of forcing them to adapt to mass-produced instruments intended for a broad patient population.

On the patient side, healthcare providers can manufacture medical devices to the exact specifications of patients. Take, for instance, customized cutting guides for knee replacements, which allow surgeons to prep and operate quicker, as well as promote recovery and healing in patients. With AM, doctors can also create functional prototypes representing a patient’s exact circumstances so they can plan operations, test different scenarios, or economically test pharmaceutical treatments. 

Today’s healthcare providers are accomplishing the previously unimaginable: from incredible advancements in research for 3D printed organs and artificial bones to prosthetic limbs for para-athletes and beyond. Many 3D printed structures can even help promote the growth of tissue or replicate more complex cavities not possible with traditional injection-molded or extrusion methods.

Now is the time for manufacturers to take advantage of this growing space. And your success boils down to your approach and ability to find the best solutions to fit patient needs. 

One of the common roadblocks preventing more widespread use and adoption of 3D printing is not reviewing the technology from the broad impact it can have on an organization. Focusing on one product line or use case can create roadblocks in the future when trying to multiply the technology to other platforms or new business models. For example, not thinking about the full scope of products in the pipeline when adding additive manufacturing into a quality system can cause unanticipated work for the next product’s roadmap.

EOS GmbH Krailling Photo: Tobias Hase (www.hase-fotografie.de)

Instead, approaching AM from a holistic perspective enables management to identify critical areas throughout the organization where 3D printing can improve operations. For this approach to be successful, key decision-makers and department heads representing multiple disciplines or business units need to be involved in the implementation process from the beginning.

From cutting-edge materials to high-value applications, the medical industry is prime for additive manufacturing to flourish. Learn more by attending my session, “Fireside chat: Emerging trends for 3D printing in healthcare,” on Tuesday, Feb. 11th at 10:10 a.m. during Additive Manufacturing Strategies 2020.

Laura Gilmour is the Global Medical Business Development Manager for EOS, the world’s leading technology supplier in the field of industrial 3D printing of metals and polymers. For more information, visit www.eos.info/en/.

Share this Article


Recent News

Will There Be a Desktop Manufacturing Revolution outside of 3D Printing?

Know Your Würth: CEO AJ Strandquist on How Würth Additive Can Change 3D Printing



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Featured

Pressing Refresh: What CEO Brad Kreger and Velo3D Have Learned About Running a 3D Printing Company

To whatever extent a business is successful thanks to specialization, businesses will nonetheless always be holistic entities. A company isn’t a bunch of compartments that all happen to share the...

Würth Additive Launches Digital Inventory Services Platform Driven by 3D Printing

Last week, at the Additive Manufacturing Users’ Group (AMUG) Conference in Chicago (March 10-14), Würth Additive Group (WAG) launched its new inventory management platform, Digital Inventory Services (DIS). WAG is...

Featured

Hypersonic Heats Up: CEO Joe Laurienti on the Success of Ursa Major’s 3D Printed Engine

“It’s only been about 24 hours now, so I’m still digesting it,” Joe Laurienti said. But even via Zoom, it was easy to notice that the CEO was satisfied. The...

Featured

3D Printing’s Next Generation of Leadership: A Conversation with Additive Minds’ Dr. Gregory Hayes

It’s easy to forget sometimes that social media isn’t reality. So, at the end of 2023, when a burst of doom and gloom started to spread across the Western world’s...